• Explore /
  • Poster
  • / Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer.

Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer.

Abstract Poster

Authors

null

Honghai Dai

Shandong Provincial Hospital, Jinan, Shandong, China

Honghai Dai , Qin Zhang , Yuan Tan , Qianqian Duan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Biologic Correlates

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4521)

DOI

10.1200/JCO.2023.41.16_suppl.4521

Abstract #

4521

Poster Bd #

13

Abstract Disclosures

Similar Posters

Poster

2021 ASCO Annual Meeting

Age affects the efficacy of immune checkpoint inhibitors in patients with advanced cancer.

Age affects the efficacy of immune checkpoint inhibitors in patients with advanced cancer.

First Author: Yongjie Wang

First Author: Xiaoting Ma

First Author: Lorenzo Pilla

First Author: Thierry Landre